Poly Medicure Ltd
Poly Medicure Ltd (POLYMED) last traded at ₹1,730, a market capitalisation of ₹17,540 crore, on a P/E of 54.8. Over the past 52 weeks the stock has ranged between ₹1,182 and ₹2,145. Poly Medicure Ltd last reported results for the quarter ended Jun 2026, with sales of ₹525 crore and net profit of ₹85 crore. The next scheduled event is an analyst meet on 27 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
Poly Medicure Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Poly Medicure Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹525 cr, up 30.3% from ₹403 cr a year earlier. Net profit was ₹85 cr, down 8.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 |
| Expenses | 305 | 310 | 321 | 298 | 329 | 382 | 424 | 400 |
| Operating profit | 115 | 114 | 119 | 106 | 115 | 111 | 110 | 125 |
| OPM % | 27% | 27% | 27% | 26% | 26% | 23% | 21% | 24% |
| Other income | 27 | 24 | 27 | 43 | 35 | 21 | 19 | 35 |
| Interest | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 6 |
| Depreciation | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 |
| Profit before tax | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 |
| Tax % | 26% | 25% | 25% | 24% | 25% | 27% | 24% | 27% |
| Net profit | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| EPS (₹) | 8.63 | 8.41 | 9.06 | 9.19 | 9.06 | 7.00 | 6.54 | 8.49 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Poly Medicure Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 785 | 922 | 1,115 | 1,375 | 1,669 | 1,875 | 1,997 |
| Operating profit | 216 | 215 | 267 | 361 | 456 | 446 | 461 |
| OPM % | 28% | 23% | 24% | 26% | 27% | 24% | 23% |
| Net profit | 136 | 147 | 179 | 258 | 339 | 321 | 313 |
| EPS (₹) | 14.17 | 15.28 | 18.69 | 26.91 | 33.41 | 31.78 | 31.09 |
TTM is the trailing twelve months to the most recent quarter.
Poly Medicure Ltd growth and returns
- 10 Years
- 16%
- 5 Years
- 19%
- 3 Years
- 19%
- TTM
- 18%
- 10 Years
- 19%
- 5 Years
- 14%
- 3 Years
- 15%
- TTM
- -11%
- 10 Years
- 24%
- 5 Years
- 13%
- 3 Years
- 7%
- 1 Year
- -18%
- 10 Years
- 15%
- 5 Years
- 13%
- 3 Years
- 13%
- Last Year
- 9%
Poly Medicure Ltd shareholding pattern
Promoters held 62.42% at Jun 2026, broadly unchanged since Jun 2025. FIIs 5.56% and DIIs 16.08%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.56% | 62.44% | 62.44% | 62.44% | 62.42% | 62.42% | 62.42% | 62.42% |
| FIIs | 11.88% | 12.33% | 11.46% | 11.41% | 9.77% | 9.41% | 5.92% | 5.56% |
| DIIs | 12.33% | 11.66% | 11.96% | 11.72% | 13.53% | 13.84% | 15.60% | 16.08% |
| Public | 13.23% | 13.57% | 14.13% | 14.43% | 14.28% | 14.34% | 16.08% | 15.94% |
| No. of shareholders | 38,352 | 60,686 | 65,583 | 71,142 | 64,400 | 67,750 | 73,414 | 73,643 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Poly Medicure Ltd events
The next scheduled event is an analyst meet on 27 Aug 2026.
- Analyst meetOne-on-one meetings with Bandhan AMC and Sparx Capital
- Record dateRecord date for final dividend of Rs 3.50 per equity share
- AGM31st Annual General Meeting including dividend declaration and director re-appointments
See the full results calendar for every Indian company reporting in the next 30 days.
Poly Medicure Ltd corporate filings
- EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding the rescheduling of a previously…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has officially cancelled the investor call that was previously…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has issued an intimation regarding a scheduled meeting with investors…
Read the full analysis - Copy of the news paper publicationCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed the transcript of its analyst and investor meeting held on…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed its Annual Report for the financial year 2025-26. This is a…
Read the full analysis - EnclosedCorp. Actionlow impact
Cruxal's analysis: Poly Medicure Limited has formally notified the stock exchanges regarding the book…
Read the full analysis - EnclosedAGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has scheduled its 31st Annual General Meeting for September 5…
Read the full analysis - EnclosedOtherslow impact
Cruxal's analysis: Poly Medicure Ltd has submitted its Business Responsibility and Sustainability Report…
Read the full analysis - EnclosedAGM/EGMlow impact
Cruxal's analysis: Poly Medicure Limited has issued a notice for its 31st Annual General Meeting (AGM) to be…
Read the full analysis - EnclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed the outcome of its analyst/investor meeting held on August…
Read the full analysis - enclosedCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has submitted its Statement of Deviation or Variation regarding the…
Read the full analysis - The company submitted the Monitoring Agency Report for the Quarter ended 30th June, 2026.Company Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has filed its Monitoring Agency Report for the quarter ended June 30…
Read the full analysis - ENCLOSEDCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - ENCLOSEDCompany Updatehigh impact
Cruxal's analysis: Poly Medicure Limited reported a robust consolidated revenue of 525.4 crore for Q1 FY27…
Read the full analysis - ENCLOSEDCompany Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has announced the grant of 1,476 stock options to its employees under…
Read the full analysis - The Company allotted the 1975 Equity Shares under ESOP Scheme, 2020.Company Updatelow impact
Cruxal's analysis: Poly Medicure Ltd has announced the allotment of 1,975 equity shares pursuant to the…
Read the full analysis - ENCLOSEDBoard Meetingmedium impact
Cruxal's analysis: Poly Medicure Limited reported consolidated revenue from operations of 525.38 crore for…
Read the full analysis - Intimation for the Investers/Analyst Call for the Financial Results of First quarter ended on 30th June, 2026.Company Updatelow impact
Cruxal's analysis: Poly Medicure Limited has issued a formal intimation regarding its upcoming earnings…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Poly Medicure Ltd
Cruxal reads every Poly Medicure Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.